ArticleReports (MDPI)2023

Favorable Outcome and Safety of Neoadjuvant Trastuzumab Emtansine (T-DM1) in a HER2-Positive Early Breast Cancer Patient with Severe Renal Disease on Hemodialysis Ineligible for Conventional Chemotherapy: A Case Report.

Suman Kalyan Natarajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.